Citi Pharma (KAR:CPHL) Other Current Payables: ₨0.00 Mil (As of . 20)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

KAR:CPHL Citi Pharma Ltd KAR:CPHL
15 GF Score
Price ₨75.17
! 1 Warning Sign
View Full Analysis

What is Citi Pharma Other Current Payables?

Citi Pharma KAR:CPHL +3.68% 15 Other Current Payables is ₨0.00 Mil as of . 20. GuruFocus rates KAR:CPHL with a GF Score™ of 15/100. The stock has 1 warning sign investors should review.

Citi Pharma's Other Current Payables for the quarter that ended in . 20 was ₨0.00 Mil.

Citi Pharma Other Current Payables Related Terms

Citi Pharma Other Current Payables Historical Data

* Premium members only.

The historical data trend for Citi Pharma's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Citi Pharma Other Current Payables Chart

Citi Pharma Annual Data
Trend
Other Current Payables

Citi Pharma Semi-Annual Data
Other Current Payables
KAR:CPHL
15GF Score
Citi Pharma Ltd KAR:CPHL
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Citi Pharma Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ₨0.00 Mil mean?
Citi Pharma (KAR:CPHL) has a Other Current Payables of ₨0.00 Mil as of . 20. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Citi Pharma and its competitors.
Is Citi Pharma's Other Current Payables too high?
Citi Pharma's current Other Current Payables is ₨0.00 Mil. Overall, Citi Pharma has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Citi Pharma's Other Current Payables compare to ZTS and UTHR?
Citi Pharma's Other Current Payables of ₨0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Drug Manufacturers company?
A good Other Current Payables depends on the Drug Manufacturers industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Citi Pharma and its competitors. Citi Pharma's current Other Current Payables is ₨0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Citi Pharma stock overvalued right now?
Citi Pharma (KAR:CPHL) has a current Other Current Payables of ₨0.00 Mil. The current Other Current Payables is ₨0.00 Mil. Citi Pharma's overall GF Score™ is 15/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Citi Pharma (KAR:CPHL), the current Other Current Payables is ₨0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Citi Pharma Business Description

Address 588 Q Block, M.A., Johar Town, Lahore, PB, PAK
Citi Pharma Ltd is engaged in the manufacturing and sale of pharmaceuticals, medical chemicals and botanical products. Its product portfolio includes API segment, Formulation segment, Cephalosporin formulation, and Nutraceuticals. The API segment includes Paracetamol, Penicillin/Amoxicillin, Levofloxacin, Cefixime/Cephalosporin, Ciprofloxacin, Cephradine, Norfloxacin, Aspirin, and Ibuprofen.
15GF Score

Get the complete analysis for KAR:CPHL

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₨75.17
Price